NEW YORK (GenomeWeb) – Immunexpress announced yesterday that it has formed a four-year alliance with the University of Amsterdam's Academic Medical Center (AMC) to characterize and clinically evaluate sepsis-related biomarker signatures of host response.

The partners will specifically evaluate proprietary biomarker signatures, as well as novel RNA, protein, and epigenetic biomarkers, with the goal of advancing Immunexpress' pipeline of host response products for the management of patients with or suspected of having sepsis.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

Nov
15
Sponsored by
Twist Bioscience

This webinar will discuss how Amyris, a biotechnology company that develops renewable products for a broad range of applications and industries, uses large-scale microbial engineering to support its manufacturing processes.

Nov
29
Sponsored by
Schott

This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.